Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FYQ06
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,659
Award facts
- Contract value 100% obligated
- $37,659.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $37,659.45 to DMS Pharmaceutical Group Inc. for EXPAREL 266 mg/20 mL vials. The order was issued on September 11, 2025, with an ultimate completion date of October 2, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA valued at $499.999 billion and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
EXPAREL (liposomal bupivacaine) is a long-acting local anesthetic used in surgical and pain management applications. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its established IDC vehicle to fulfill specific delivery orders for branded and generic prescription medications, biologics, and medical consumables across military health facilities. The company's robust contract portfolio with DLA demonstrates its capability to reliably distribute specialized pharmaceutical products to support defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FYQ06?
SPE2DB25FYQ06 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FYQ06 worth?
The government has obligated $37,659 on SPE2DB25FYQ06.
Is contract SPE2DB25FYQ06 an order under another contract?
Yes. SPE2DB25FYQ06 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYQ06 competed?
The extent of competition for SPE2DB25FYQ06 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award